Cas:792915-20-9 3,3-Dimethylpyrrolidine hydrochloride (1:1) manufacturer & supplier

We serve Chemical Name:3,3-Dimethylpyrrolidine hydrochloride (1:1) CAS:792915-20-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,3-Dimethylpyrrolidine hydrochloride (1:1)

Chemical Name:3,3-Dimethylpyrrolidine hydrochloride (1:1)
CAS.NO:792915-20-9
Synonyms:3,3-dimethylpyrrolidine,hydrochloride;3,3-Dimethylpyrrolidine hydrochloride (1:1);Pyrrolidine, 3,3-dimethyl-, hydrochloride (1:1)
Molecular Formula:C6H14ClN
Molecular Weight:135.635
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.03000
Exact Mass:135.081482
LogP:2.13670

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3,3-dimethylpyrrolidine,hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrrolidine, 3,3-dimethyl-, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,3-Dimethylpyrrolidine hydrochloride (1:1) Use and application,Pyrrolidine, 3,3-dimethyl-, hydrochloride (1:1) technical grade,usp/ep/jp grade.


Related News: Health officials said it remained unclear where he had developed the disease. 3,3-Dimethylpyrrolidine hydrochloride (1:1) manufacturer Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 3,3-Dimethylpyrrolidine hydrochloride (1:1) supplier Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 3,3-Dimethylpyrrolidine hydrochloride (1:1) vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 3,3-Dimethylpyrrolidine hydrochloride (1:1) factory Health officials said it remained unclear where he had developed the disease.